DR. AHMED A TAWAKOL, MD
Osteopathic Medicine in Boston, MA
License number
Massachusetts 80137
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Massachusetts 80137
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
55 Cardiac UNIT ASSOCIATES, Boston, MA 02114
Phone
(617) 724-6750
(617) 724-6767 (Fax)
(617) 726-0786
(617) 724-4152 (Fax)
(617) 724-6767 (Fax)
(617) 726-0786
(617) 724-4152 (Fax)
Personal information
See more information about AHMED A TAWAKOL at radaris.comName
Address
Phone
116A School St, Lexington, MA 02421
22 Clubhouse Ln, Wayland, MA 01778
97 Charlesbank Way, Waltham, MA 02453
97 Charlesbank Way, Waltham, MA 02453
97B Charlesbank Way, Waltham, MA 02453
Organization information
See more information about AHMED A TAWAKOL at bizstanding.comAhmed Tawakol MD
55 Fruit St, Boston, MA 02114
Industry:
Cardiologist, Internist
Phone:
(617) 724-3650 (Phone)
Ahmed A. Tawakol
Professional information
Dr. Ahmed A Tawakol, Boston MA - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
55 Fruit St SUITE 3, Boston 02114
(617) 726-2000 (Phone), (617) 724-6767 (Fax)
27 Deer Run, Wayland 01778
CARDIAC MR PET CT PROGRAM
165 Cambridge St SUITE 400, Boston 02114
(617) 726-0786 (Phone)
(617) 726-2000 (Phone), (617) 724-6767 (Fax)
27 Deer Run, Wayland 01778
CARDIAC MR PET CT PROGRAM
165 Cambridge St SUITE 400, Boston 02114
(617) 726-0786 (Phone)
Procedures:
Cardiac Catheterization (incl. Coronary Angiography), Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
Conditions:
Angina and Acute Coronary Syndrome, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomyopathy, Carotid Artery Disease, Congestive Heart Failure, Coronary Artery Disease (CAD), Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Mitral Valve Disease, Syncope
Certifications:
Cardiovascular Disease, 1999, Internal Medicine, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
55 Fruit St SUITE 3, Boston 02114
27 Deer Run, Wayland 01778
CARDIAC MR PET CT PROGRAM
165 Cambridge St SUITE 400, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
27 Deer Run, Wayland 01778
CARDIAC MR PET CT PROGRAM
165 Cambridge St SUITE 400, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
Education:
Medical School
Stanford University
Graduated: 1992
Brigham and Womens Hospital
Stanford University
Graduated: 1992
Brigham and Womens Hospital
Ahmed A Tawakol, Boston MA
Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology
Work:
Massachusetts General Hospital
55 Fruit St, Boston, MA 02114
55 Fruit St, Boston, MA 02114
Education:
Stanford University (1992)
Detection And Therapy Of Vulnerable Plaque With Photodynamic Compounds
US Patent:
2003010, Jun 5, 2003
Filed:
Jun 4, 2002
Appl. No.:
10/163744
Inventors:
Michael Hamblin - Boston MA, US
Ahmed Tawakol - Boston MA, US
Tayaba Hassan - Boston MA, US
Alan Fischman - Boston MA, US
James Muller - Boston MA, US
Rox Anderson - Boston MA, US
Ahmed Tawakol - Boston MA, US
Tayaba Hassan - Boston MA, US
Alan Fischman - Boston MA, US
James Muller - Boston MA, US
Rox Anderson - Boston MA, US
International Classification:
A61K049/00, A61K038/17, A61K031/704, A61K031/409, A61K039/395, A61K009/127, A61N001/30
US Classification:
424/185100, 424/450000, 514/002000, 514/034000, 604/020000, 424/130100, 424/009600, 514/410000
Abstract:
The present invention relates to methods for selectively targeting Photodynamic Therapy (“PDT”) to inflammatory components of vulnerable plaques. As such, the present invention provides methods for the identification of vulnerable plaques, as well as methods to treat vulnerable plaques by selectively targeting and/or eliminating the inflammatory components of vulnerable plaques. The invention further relates to a specially designed intravascular device that delivers excitation light to the plaque surface inside the artery and receives emitted fluorescence light when a fluorescent signal is detected.
Detection And Therapy Of Vulnerable Plaque With Fluorescent And/Or Radiolabeled Compositions
US Patent:
2006007, Apr 6, 2006
Filed:
Aug 9, 2002
Appl. No.:
10/216026
Inventors:
Alan Fischman - Boston MA, US
Michael Hamblin - Boston MA, US
Ahmed Tawakol - Boston MA, US
Tayyaba Hasan - Boston MA, US
James Muller - Boston MA, US
Rox Anderson - Boston MA, US
David Elmaleh - Boston MA, US
Henry Gewirtz - Boston MA, US
Michael Hamblin - Boston MA, US
Ahmed Tawakol - Boston MA, US
Tayyaba Hasan - Boston MA, US
James Muller - Boston MA, US
Rox Anderson - Boston MA, US
David Elmaleh - Boston MA, US
Henry Gewirtz - Boston MA, US
International Classification:
A61K 49/00, A61K 39/395, C07K 16/46
US Classification:
424009600, 424178100, 530391100
Abstract:
The present invention relates to methods for selectively targeting Photodynamic Therapy (“PDT”) to inflammatory components of vulnerable plaques. As such, the present invention provides methods for the identification of vulnerable plaques, using fluorescent compositions, which include photosensitizer compoisitions, and/or radiolabeled compounds, as well as methods to treat vulnerable plaques by selectively targeting and/or eliminating the inflammatory components of vulnerable plaques.
Methods And Devices For Detection And Therapy Of Atheromatous Plaque
US Patent:
2007025, Nov 8, 2007
Filed:
Nov 16, 2006
Appl. No.:
11/600613
Inventors:
Alan Fischman - Boston MA, US
Michael Hamblin - Revere MA, US
Ahmed Tawakol - Boston MA, US
Tayyaba Hasan - Boston MA, US
James Muller - Boston MA, US
Rox Anderson - Boston MA, US
David Elmaleh - Boston MA, US
Michael Hamblin - Revere MA, US
Ahmed Tawakol - Boston MA, US
Tayyaba Hasan - Boston MA, US
James Muller - Boston MA, US
Rox Anderson - Boston MA, US
David Elmaleh - Boston MA, US
International Classification:
A61K 49/00
US Classification:
424009710
Abstract:
The present invention relates to devices for detection and therapy of active atheromatous plaque and/or thin-capped fibro-atheroma (“vulnerable plaque”), using selectively targeted fluorescent, radiolabeled, or fluorescent and radiolabeled compositions. The present invention further relates to methods and devices for detection and therapy of active atheromatous plaques and/or vulnerable plaques, using selectively targeted beta-emitting compositions, optionally comprising fluorescent compositions.
Methods And Devices For Detection And Therapy Of Atheromatous Plaque
US Patent:
2003008, May 1, 2003
Filed:
Aug 9, 2002
Appl. No.:
10/215958
Inventors:
Alan Fischman - Boston MA, US
Michael Hamblin - Boston MA, US
Ahmed Tawakol - Boston MA, US
Tayyaba Hasan - Boston MA, US
James Muller - Boston MA, US
Rox Anderson - Boston MA, US
David Elmaleh - Boston MA, US
Michael Hamblin - Boston MA, US
Ahmed Tawakol - Boston MA, US
Tayyaba Hasan - Boston MA, US
James Muller - Boston MA, US
Rox Anderson - Boston MA, US
David Elmaleh - Boston MA, US
International Classification:
A61K049/00, A61N001/30
US Classification:
424/009600, 600/317000, 604/020000
Abstract:
The present invention relates to devices for detection and therapy of active atheromatous plaque and/or thin-capped fibro-atheroma (“vulnerable plaque”), using selectively targeted fluorescent, radiolabeled, or fluorescent and radiolabeled compositions. The present invention further relates to methods and devices for detection and theraphy of active atheromatous plaques and/or vulnerable plaques, using selectively targeted beta-emitting compositions, optionally comprising fluorescent compositions.